NCT06889545

Brief Summary

Frailty is a significant risk factor for postoperative complications and functional decline. Preoperative assessment of frailty is therefore recommended in all older adults. However, despite the availability of many frailty tools, few have been tested in the preoperative setting and there is little comparison of their predictive value in identifying patients at risk. The aim of this study is to investigate which of the following instruments for determining frailty has the highest predictive power with regard to the occurrence of postoperative complications: Risk Analysis Index, Clinical Frailty Scale, the Groningen Frailty Indicator, the Edmonton Frail Scale and the LUCAS-FI. The aim of this research project is to identify a suitable frailty instrument for preoperative risk stratification of older patients during the premedication visit.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
584

participants targeted

Target at P75+ for all trials

Timeline
17mo left

Started Apr 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress43%
Apr 2025Oct 2027

First Submitted

Initial submission to the registry

February 23, 2025

Completed
26 days until next milestone

First Posted

Study publicly available on registry

March 21, 2025

Completed
25 days until next milestone

Study Start

First participant enrolled

April 15, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2027

Last Updated

April 3, 2025

Status Verified

March 1, 2025

Enrollment Period

2 years

First QC Date

February 23, 2025

Last Update Submit

March 30, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Complications in the first 30 days after surgery

    Measured by Clavien-Dindo classification

    30 days

Secondary Outcomes (12)

  • Functional state (activities of daily living)

    one, three and six months after surgery

  • Postoperative Quality of Recovery

    postoperative day 2

  • Muscle loss during hospitalisation

    From date of enrollment, up to 4 weeks after surgery

  • Postoperative delirium

    postoperative day 1 to 5

  • Length of stay

    from day of surgery, up to 4 weeks after surgery

  • +7 more secondary outcomes

Study Arms (1)

Older patients

Patients at 70 years and above scheduled for surgery

Other: Assessment of frailty using multiple tools

Interventions

This is an observational study without any intervention. Frailty is assessed using multiple tools and postoperative outcome is compared.

Older patients

Eligibility Criteria

Age70 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients of the Medical University Centre Hamburg, Germany

You may qualify if:

  • years and older
  • scheduled surgery
  • estimated time of surgery 120 Minutes or more

You may not qualify if:

  • insufficient German language skills (for cognitive testing)
  • mental retardation
  • relevant psychiatric disorder (not allowing for cognitive testing)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Medical Centre Hamburg

Hamburg, 22046, Germany

Location

MeSH Terms

Conditions

FrailtySarcopenia

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsMuscular AtrophyNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalSigns and Symptoms

Study Officials

  • Dr. Cynthia Olotu, MD

    University Medical Centre Hamburg

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dr. Cynthia Olotu, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 23, 2025

First Posted

March 21, 2025

Study Start

April 15, 2025

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

October 1, 2027

Last Updated

April 3, 2025

Record last verified: 2025-03

Locations